JP2013530202A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013530202A5 JP2013530202A5 JP2013517372A JP2013517372A JP2013530202A5 JP 2013530202 A5 JP2013530202 A5 JP 2013530202A5 JP 2013517372 A JP2013517372 A JP 2013517372A JP 2013517372 A JP2013517372 A JP 2013517372A JP 2013530202 A5 JP2013530202 A5 JP 2013530202A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- hal
- mixtures
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10168833.1 | 2010-07-08 | ||
| EP10168833 | 2010-07-08 | ||
| US36274610P | 2010-07-09 | 2010-07-09 | |
| US61/362,746 | 2010-07-09 | ||
| PCT/EP2011/061372 WO2012004287A1 (en) | 2010-07-08 | 2011-07-06 | 5-(biphenyl-4-yl)-3-phenyl-1,2,4-oxadiazolyl derivatives as ligands on the sphingosine 1-phosphate (s1p) receptors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013530202A JP2013530202A (ja) | 2013-07-25 |
| JP2013530202A5 true JP2013530202A5 (cg-RX-API-DMAC7.html) | 2015-11-05 |
| JP6014589B2 JP6014589B2 (ja) | 2016-10-25 |
Family
ID=42341535
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013517372A Expired - Fee Related JP6014589B2 (ja) | 2010-07-08 | 2011-07-06 | スフィンゴシン１−リン酸（ｓ１ｐ）受容体上のリガンドとしての５−（ビフェニル−４−イル）−３−フェニル−１，２，４−オキサジアゾリル誘導体 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9029405B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2590956B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6014589B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20140003379A (cg-RX-API-DMAC7.html) |
| CN (1) | CN103097365B (cg-RX-API-DMAC7.html) |
| AR (1) | AR082132A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2011275854B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2804473C (cg-RX-API-DMAC7.html) |
| EA (1) | EA201300092A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2586145T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL224071B (cg-RX-API-DMAC7.html) |
| MX (1) | MX2012015021A (cg-RX-API-DMAC7.html) |
| SG (1) | SG186872A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TW201206429A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2012004287A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102250035A (zh) * | 2011-06-10 | 2011-11-23 | 北京富卡生物技术有限公司 | 二芳基取代-1，3，4-噁二唑化合物的合成方法和其药物用途 |
| CN107857760A (zh) * | 2017-11-21 | 2018-03-30 | 南京天翔医药科技有限公司 | 鞘氨醇‑1‑磷酸受体调节剂及其应用 |
| FI4081511T3 (fi) * | 2019-12-23 | 2024-10-24 | Sitryx Therapeutics Ltd | Karboksijohdannaisia, joilla on anti-inflammatorisia ominaisuuksia |
| EP4126827B1 (en) * | 2020-03-27 | 2024-11-20 | Receptos LLC | Sphingosine 1 phosphate receptor modulators |
| WO2022212769A1 (en) * | 2021-03-31 | 2022-10-06 | Washington University | Compositions for binding sphingosine-1-phosphate receptor 1 (s1p1), imaging of s1p1, and processes for preparation thereof |
| WO2022220608A1 (ko) * | 2021-04-14 | 2022-10-20 | 주식회사 엘지화학 | 스핑고신-1-인산 수용체 효능제 합성을 위한 중간체의 제조방법 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE177439T1 (de) | 1994-11-05 | 1999-03-15 | Basf Ag | Melaminharze |
| CA2547198A1 (en) * | 2003-12-17 | 2005-06-30 | Merck & Co., Inc. | (3,4-disubstituted)propanoic carboxylates as s1p (edg) receptor agonists |
| US20060223866A1 (en) * | 2004-08-13 | 2006-10-05 | Praecis Pharmaceuticals, Inc. | Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity |
| GB0511684D0 (en) * | 2005-06-08 | 2005-07-13 | Novartis Ag | Organic compounds |
| EP1893591A1 (en) | 2005-06-08 | 2008-03-05 | Novartis AG | POLYCYCLIC OXADIAZOLES OR I SOXAZOLES AND THEIR USE AS SlP RECEPTOR LIGANDS |
| TWI404706B (zh) * | 2006-01-11 | 2013-08-11 | Actelion Pharmaceuticals Ltd | 新穎噻吩衍生物 |
| GB0601744D0 (en) * | 2006-01-27 | 2006-03-08 | Novartis Ag | Organic compounds |
| JP2009269819A (ja) * | 2006-08-25 | 2009-11-19 | Asahi Kasei Pharma Kk | アミン化合物 |
| CA2664268A1 (en) * | 2006-09-29 | 2008-04-03 | Novartis Ag | Diaryl oxadiazol derivatives |
| KR20100075608A (ko) * | 2007-10-04 | 2010-07-02 | 메르크 세로노 에스. 에이. | 옥사다이졸 유도체 |
| TW201000099A (en) * | 2008-06-20 | 2010-01-01 | Amgen Inc | S1P1 receptor agonists and use thereof |
| EP2241558A1 (en) * | 2009-04-03 | 2010-10-20 | Merck Serono SA | Oxadiazole derivatives |
-
2011
- 2011-07-01 TW TW100122179A patent/TW201206429A/zh unknown
- 2011-07-06 CA CA2804473A patent/CA2804473C/en not_active Expired - Fee Related
- 2011-07-06 JP JP2013517372A patent/JP6014589B2/ja not_active Expired - Fee Related
- 2011-07-06 EP EP11729318.3A patent/EP2590956B1/en not_active Not-in-force
- 2011-07-06 AU AU2011275854A patent/AU2011275854B2/en not_active Ceased
- 2011-07-06 EA EA201300092A patent/EA201300092A1/ru unknown
- 2011-07-06 WO PCT/EP2011/061372 patent/WO2012004287A1/en not_active Ceased
- 2011-07-06 CN CN201180033823.9A patent/CN103097365B/zh not_active Expired - Fee Related
- 2011-07-06 MX MX2012015021A patent/MX2012015021A/es not_active Application Discontinuation
- 2011-07-06 SG SG2012096533A patent/SG186872A1/en unknown
- 2011-07-06 ES ES11729318.3T patent/ES2586145T3/es active Active
- 2011-07-06 US US13/809,013 patent/US9029405B2/en not_active Expired - Fee Related
- 2011-07-06 KR KR20137003335A patent/KR20140003379A/ko not_active Withdrawn
- 2011-07-08 AR ARP110102449 patent/AR082132A1/es not_active Application Discontinuation
-
2012
- 2012-12-31 IL IL224071A patent/IL224071B/en active IP Right Grant